Cite
MLA Citation
Marc‐Eric Halatsch et al.. “Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma.” British journal of pharmacology, vol. 176, 2019, pp. 3681–3694. http://access.bl.uk/ark:/81055/vdc_100091263409.0x00005c